PAPER
Application of the Blaise Reaction to an Expedient Synthesis of a Statin Intermediate
2631
In conclusion, we have developed an efficient and practi- 13C NMR (100 MHz, CDCl
): d (keto form) = 195.6, 166.8, 140.0,
3
1
2
133.9, 132.3, 129.5, 127.5, 119.2, 61.5, 48.8, 14.0. d (enol form) =
cal in situ activation of zinc metal by treatment with an
catalytic amount of organic acid. The effectiveness of this
activation (use of 0.5 mol% of methanesulfonic acid)
leads to a significant reduction in the equivalents of zinc
and bromoacetate in the Blaise reaction to 2 and 1.6
equivalents, respectively. The established protocol was
successfully applied to the Blaise reactions of various ni-
1
1
72.6, 171.1, 135.8, 133.8, 131.2, 130.2, 127.3, 121.0, 93.2, 60.6,
4.3.
MS (ESI): m/z = 367 (2 M + Na), 195 (M + Na), 173 (M + H).
1
3
Ethyl 3-(3-Methoxyphenyl)- 3-oxopropionate
1
H NMR (400 MHz, CDCl ): d (keto form, 75%) = 7.50–7.35 (m, 3
3
H), 7.14 (m, 1 H), 4.21 (q, J = 7.2 Hz, 2 H), 3. 98 (s, 2 H), 3.86 (s,
triles and the expedient synthesis of tert-butyl (S)-6-chlo- 3 H), 1.26 (t, J = 7.2 Hz, 3 H). d (enol form, 25%) = 12.57 (s, 1 H),
ro-5-hydroxy-3-oxohexanoate (1).
7.50–7.35 (m, 3 H), 5.65 (s, 1 H), 4.27 (q, J = 7.2 Hz, 2 H), 3.84 (s,
3
H), 1.34 (t, J = 7.2 Hz, 3 H).
1
3
C NMR (100 MHz, CDCl ): d (keto form) = 192.4, 167.5, 160.0,
3
1
37.4, 129.8, 121.2, 120.4, 112.5, 61.5, 55.5, 46.1, 14.1. d (enol
b-Keto Esters; General Procedure
form) = 173.2, 171.3, 159.7, 134.9, 129.6, 118.5, 117.3, 111.2, 91.8,
To a stirred suspension of commercial zinc (zinc dust, <10 micron,
6
0.4, 55.4, 14.3.
Aldrich, 2.0 equiv) in THF (5 mL/g) was added MeSO H (1 mol%)
3
at r.t. The mixture was refluxed for 10 min and nitrile was added.
To the mixture was added ethyl bromoacetate (1.6 equiv) over 1 h
using syringe pump. After 30 min, the mixture was cooled to 0–5 °C
and aq 3 N HCl (4 mL/g) solution was added dropwise. After 3–24
h, all the organic volatiles are removed in vacuo and the remaining
mixture was extracted with EtOAc (10 mL/g). The separated organ-
ic layer was washed with H O, dried (MgSO ) and concentrated.
MS (ESI): m/z = 467 (2 M + Na), 245 (M + Na), 223 (M + H).
(S)-4-Chloro-3-hydroxybutyronitrile (2a)
To a stirred solution of NaCN (92.6 g, 1.89 mol) in H O (560 mL)
2
was added dropwise conc. H SO (92.0 g, 0.94 mol) over 1 h at
2
4
–25 °C to adjust the pH of the reaction mixture in the range of 7.7
to 7.9. To the mixture was added dropwise (S)-epichlorohydrin
(139.8 g, 1.51 mol). After 12 h, the formed solid was filtered and the
filtrate was extracted with CH Cl (370 g). Concentration of the
2
4
Column chromatography of the residue afforded the desired product
Table 2).
(
2
2
separated organic layer and vacuum distillation of the residue pro-
vided 157.5 g (87%) of 2a as a colorless oil; bp 110 °C/1 mmHg.
1
3
Ethyl 3-Oxoheptanoate
1
H NMR (400 MHz, CDCl ): d = 4.20 (q, J = 7.2 Hz, 2 H), 3.43 (s,
H), 2.54 (t, J = 7.2 Hz, 2 H), 1.59 (m, 2 H), 1.28 (t, J = 7.2 Hz, 3
H), 0.91 (t, J = 7.2 Hz, 3 H).
1
3
H NMR (400 MHz, CDCl ): d = 4.21 (m, 1 H), 3.71 (dd, J = 11.6,
3
2
4
6
.8 Hz, 1 H), 3.67 (dd, J = 11.6, 5.6 Hz, 1 H), 2.74 (dd, J = 16.8,
.0 Hz, 1 H), 2.69 (dd, J = 16.8, 6.4 Hz, 1 H), 2.61 (d, J = 5.6 Hz,
1
3
C NMR (100 MHz, CDCl ): d = 203.0, 167.3, 61.3, 49.3, 42.7,
5.5, 22.1, 14.1, 11.7, 13.8.
1 H).
3
2
13
C NMR (100 MHz, CDCl ): d = 117.0, 67.2, 47.2, 23.2.
3
MS (ESI): m/z = 367 (2 M + Na), 195 (M + Na), 173 (M + H).
EI-MS: m/z = 122 (M + H + 2), 120 (M + H), 81 (M + 2 – CH CN),
2
7
9 (M – CH CN).
1
4
2
Ethyl 3-Cyclopropyl-3-oxopropionate
1
H NMR (400 MHz, CDCl ): d = 4.21 (q, J = 7.2 Hz, 2 H), 3.57 (s,
H), 2.04 (m, 1 H), 1.29 (t, J = 7.2 Hz, 3 H), 1.12 (m, 2 H), 0.97
3
(
S)-4-Chloro-3-trimethylsilyloxybutyronitrile (2b)
2
To a stirred solution of 2a (150 g, 1.25 mol) in toluene (700 mL)
(
m, 2 H).
was added hexamethyldisilazane (HMDS, 121 g, 0.75 mol) at 0 °C.
To the mixture was added Me SiCl (6.9 g, 0.05 mol) and the mix-
ture was warmed to r.t. After 8 h, aq 10% NH Cl solution was added
1
3
C NMR (100 MHz, CDCl ): d = 202.8, 167.2, 61.3, 50.0, 20.7,
3
3
1
4.1, 11.7.
4
and the organic layer was separated. Concentration of the separated
organic layer provided 229.5 g (98%) of 2b as a colorless oil.
MS (ESI): m/z = 335 (2 M + Na), 179 (M + Na), 157 (M + H).
Ethyl 4-(3,4-Dimethoxyphenyl)-3-oxobutyrate15
1
H NMR (400 MHz, CDCl ): d = 4.12 (m, 1 H), 3.54 (dd, J = 11.4,
3
1
H NMR (400 MHz, CDCl ): d = 6.85–6.71 (m, 3 H), 4.17 (q,
4.8 Hz, 1 H), 3.48 (dd, J = 11.4, 7.2 Hz, 1 H), 2.70 (dd, J = 16.6,
4.6 Hz, 1 H), 2.62 (dd, J = 16.6, 6.6 Hz, 1 H), 0.21 (s, 9 H).
3
J = 7.2 Hz, 2 H), 3.87 (s, 6 H), 3.76 (s, 2 H), 3.44 (s, 2 H), 1.27 (t,
J = 7.2 Hz, 3 H).
13
C NMR (100 MHz, CDCl ): d = 116.8, 68.5, 46.5, 24.1, 0.0.
3
1
3
C NMR (100 MHz, CDCl ): d = 200.8, 167.1, 149.2, 148.4, 125.6,
3
EIMS: m/z = 367 (2 M – CH ), 284 (2 M + H – TMS – CN), 264 (2
M – H – TMS – CN – H O), 176 (M – CH ), 93 (M + H – TMS –
3
1
21.8, 112.5, 111.4, 61.4, 55.9, 49.6, 48.0, 14.1.
2
3
MS (ESI): m/z = 289 (M + Na), 267 (M + H).
CN), 75 (M + H – TMS – CN – H O), 73 (TMS).
2
1
5
Ethyl 4-(4-Methoxyphenyl)-3-oxobutyrate
tert-Butyl (S)-6-Chloro-5-hydroxy-3-oxohexanoate (1)
To a stirred suspension of commercial zinc dust (8.3 g, 126 mmol)
1
H NMR (400 MHz, CDCl ): d = 7.12 (m, 2 H), 6.87 (m, 2 H), 4.17
q, J = 7.2 Hz, 2 H), 3.80 (s, 3 H), 3.76 (s, 2 H), 3.43 (s, 2 H), 1.26
3
(
(
1
in THF (60 mL) was added MeSO H (60 mg, 0.6 mmol) at r.t. The
3
t, J = 7.2 Hz, 3 H).
3
mixture was refluxed for 10 min and (S)-4-chloro-3-trimethylsily-
loxybutyronitrile (2b; 12.0 g, 63 mmol) was added. To the mixture
was added tert-butyl bromoacetate (19.7 g, 101 mmol) over 1 h us-
ing a syringe pump. After 30 min, the mixture was cooled to 0–5 °C
and aq 3 N HCl (40 mL) was added dropwise. After 2 h, all the or-
ganic volatiles were removed in vacuo and the remaining mixture
was extracted with EtOAc (60 mL). The separated organic layer
was washed with H O, dried (MgSO ) and concentrated. Column
C NMR (100 MHz, CDCl ): d = 200.8, 167.1, 158.9, 130.6, 125.2,
3
1
14.3, 61.3, 55.2, 49.1, 48.1, 14.0.
MS (ESI): m/z = 495 (2 M + Na), 259 (M + Na), 237 (M + H).
Ethyl 3-(2-Bromophenyl)-3-oxopropionate13
H NMR (400 MHz, CDCl ): d (keto form, 60%) = 7.64–7.24 (m, 4
H), 4.18 (q, J = 7.2 Hz, 2 H), 4.02 (s, 2 H), 1.24 (t, J = 7.2 Hz, 3 H).
d (enol form, 40%) = 12.42 (s, 1 H), 7.64–7.24 (m, 4 H), 5.45 (s, 1
H), 4.27 (q, J = 7.2 Hz, 2 H), 1.34 (t, J = 7.2 Hz, 3 H).
1
3
2
4
chromatography (EtOAc–hexane, 1:3) of the residue afforded 12.1
25
9b
g (85%) of 1 as a viscous oil; [a] –24.4 (c = 1.0, CHCl ) {Lit.
D
3
25
[
a]D –24.9 (c = 1.4, CHCl )}.
3
Synthesis 2004, No. 16, 2629–2632 © Thieme Stuttgart · New York